Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seliciclib for Cushing Disease
NCT03774446Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Nov 2018
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seliciclib in Cushing's disease (CD), sponsored by Cedars-Sinai Medical Center. Started Nov 2018; status: completed.
02
Drugs
seliciclib
03
Conditions
Cushing's disease (CD)
Beyond the preview
Go deeper on NCT03774446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774446.